Tempus AI Shares Are Trading Higher After the Company Announced It Received U.S. FDA 510(k) Clearance for Tempus ECG-AF Device That Uses AI to Help Identify Patients Who May Be at Increased Risk of Atrial Fibrillation/flutter
Tempus AI股价上涨，因为该公司宣布其Tempus ECG-AF设备获得美国FDA 510(k)许可，该设备使用人工智能帮助识别可能有房颤/扑动风险的患者。
